BACKGROUND: Hepatitis G virus (HGV) is an RNA virus. It is mainly transmitted through exposure to contaminated blood although other routes may also exist. Patients with chronic renal failure (CRF) are at high risk of acquiring HGV because they require frequent blood transfusions. Ongoing HGV infection can be only diagnosed by demonstrating viremia in patient sample by reverse transcriptase (RT) PCR. Antibodies to the envelop protein E2 (anti E2) of HGV is an indicator of virus clearance and testify past HGV contact. This cross sectional study was done to assess the frequency of HGV exposure (ongoing and past infection) in Egyptian children with CRF and to study the possible risk factors of infection. METHODS: This study included 100 children with CRF [34 on regular haemodialysis (HD) and 66 before the start of dialysis (predialysis)]. All patients sera were tested for HGV RNA by RT-PCR, anti E2, hepatitis C virus (HCV) antibody, hepatitis B surface antigen (HBsAg), and hepatitis B core antibody (HBcAB). Twenty five healthy children of matched age & sex were used as controls. RESULTS: HGV RNA was positive in 9 (26.5%) of HD and 9 (13.6%) of predialysis children. Anti E2 was positive in 14 (41.2%) of HD and 19 (28.8%) of predialysis children.In comparison to controls; CRF (n = 100); HD and predialysis children had significantly higher prevalence of anti E2 [4% VS 33% for all CRF cases; (p = 0.002)& 41.2% (p = 0.002) and 28.8% (p = 0.01); for HD and predialysis groups; respectively]. HGV RNA was significantly more prevalent only in HD children in comparison to controls (p = 0.03). HD and predialysis children did not have significant difference in the prevalence of HGV RNA (p = 0.16) or anti E2 (p = 0.26).HGV exposure was not correlated with positivity of anti HCV (p = 0.32), HCV RNA (0.09), HBsAg/HBcAB (p = 1), age (p = 0.06), or gender (p = 0.83). It was significantly correlated with duration of the disease (p < 0.001). Ongoing HGV infection was significantly more prevalent with frequent blood transfusion (p < 0.001). There were no significant differences in serum levels of ALT (p = 0.09), total bilirubin (p = 0.1) and albumin (p = 0.06) in children with ongoing infection in comparison to healthy controls. CONCLUSIONS: The frequency of HGV exposure in Egyptian children with CRF appears to be high and is mainly related to frequent blood transfusions and longer disease duration. HGV infection in these children is not associated with significant changes in hepatic biochemical parameters.
BACKGROUND:Hepatitis G virus (HGV) is an RNA virus. It is mainly transmitted through exposure to contaminated blood although other routes may also exist. Patients with chronic renal failure (CRF) are at high risk of acquiring HGV because they require frequent blood transfusions. Ongoing HGV infection can be only diagnosed by demonstrating viremia in patient sample by reverse transcriptase (RT) PCR. Antibodies to the envelop protein E2 (anti E2) of HGV is an indicator of virus clearance and testify past HGV contact. This cross sectional study was done to assess the frequency of HGV exposure (ongoing and past infection) in Egyptian children with CRF and to study the possible risk factors of infection. METHODS: This study included 100 children with CRF [34 on regular haemodialysis (HD) and 66 before the start of dialysis (predialysis)]. All patients sera were tested for HGV RNA by RT-PCR, anti E2, hepatitis C virus (HCV) antibody, hepatitis B surface antigen (HBsAg), and hepatitis B core antibody (HBcAB). Twenty five healthy children of matched age & sex were used as controls. RESULTS:HGV RNA was positive in 9 (26.5%) of HD and 9 (13.6%) of predialysis children. Anti E2 was positive in 14 (41.2%) of HD and 19 (28.8%) of predialysis children.In comparison to controls; CRF (n = 100); HD and predialysis children had significantly higher prevalence of anti E2 [4% VS 33% for all CRF cases; (p = 0.002)& 41.2% (p = 0.002) and 28.8% (p = 0.01); for HD and predialysis groups; respectively]. HGV RNA was significantly more prevalent only in HDchildren in comparison to controls (p = 0.03). HD and predialysis children did not have significant difference in the prevalence of HGV RNA (p = 0.16) or anti E2 (p = 0.26).HGV exposure was not correlated with positivity of anti HCV (p = 0.32), HCV RNA (0.09), HBsAg/HBcAB (p = 1), age (p = 0.06), or gender (p = 0.83). It was significantly correlated with duration of the disease (p < 0.001). Ongoing HGV infection was significantly more prevalent with frequent blood transfusion (p < 0.001). There were no significant differences in serum levels of ALT (p = 0.09), total bilirubin (p = 0.1) and albumin (p = 0.06) in children with ongoing infection in comparison to healthy controls. CONCLUSIONS: The frequency of HGV exposure in Egyptian children with CRF appears to be high and is mainly related to frequent blood transfusions and longer disease duration. HGV infection in these children is not associated with significant changes in hepatic biochemical parameters.
Authors: M de Medina; M Ashby; V Schlüter; M Hill; B Leclerq; J P Pennell; L J Jeffers; K R Reddy; E R Schiff; G Hess; G O Perez Journal: Am J Kidney Dis Date: 1998-02 Impact factor: 8.860
Authors: T L Yashina; M O Favorov; Y E Khudyakov; H A Fields; O O Znoiko; T V Shkurko; T Bonafonte; J S Sevall; M S Agopian; J B Peter Journal: J Infect Dis Date: 1997-06 Impact factor: 5.226
Authors: F Fabrizi; G Lunghi; G Bacchini; M Corti; I Guarnori; L Raffaele; G Erba; A Pagano; F Locatelli Journal: Nephrol Dial Transplant Date: 1997-08 Impact factor: 5.992
Authors: L D Moaven; S A Locarnini; D S Bowden; J P Kim; A Breschkin; R McCaw; A Yun; J Wages; B Jones; P Angus Journal: J Hepatol Date: 1997-10 Impact factor: 25.083
Authors: K Masuko; T Mitsui; K Iwano; C Yamazaki; K Okuda; T Meguro; N Murayama; T Inoue; F Tsuda; H Okamoto; Y Miyakawa; M Mayumi Journal: N Engl J Med Date: 1996-06-06 Impact factor: 91.245
Authors: Marcus Vinícius Guimarães Lacerda; Victor Hugo Aquino; Mario Luis Garcia de Figueiredo; Evan P Williams; Colleen B Jonsson; Mohd Jaseem Khan; Márcio Roberto Teixeira Nunes; Clayton Pereira Silva de Lima; Luiz Tadeu Moraes Figueiredo; Mônica Regina Farias Costa; Maria Paula Gomes Mourão Journal: Arch Virol Date: 2022-07-16 Impact factor: 2.685
Authors: Maria Teresa M Giret; João Luiz Miraglia; Maria Cecília Araripe Sucupira; Anna Nishiya; José Eduardo Levi; Ricardo S Diaz; Ester C Sabino; Esper G Kallas Journal: PLoS One Date: 2011-04-05 Impact factor: 3.240
Authors: Saeed Soleiman-Meigooni; Ali Asgari; Seyyed Javad Hoseini-Shokouh; Jalil Rajabi; Mohammad Hassan Kazemi-Galougahi; Mohammad Moshtaghi Journal: Electron Physician Date: 2015-03-01